ProPharma leads the life sciences industry, continuously advancing and strengthening its role in the field. Stay informed with the latest news and updates from ProPharma
The Weinberg Group (now ProPharma Group), the leading FDA consulting firm, is pleased to announce that Steve Jensen has joined us as Senior Vice President, Head of Regulatory Consulting. Steve has...
ProPharma Group kicked off 2015 by hosting the January BioKansas BioBreak event at our Overland Park office on January 15th. Each month, BioKansas works with local life science companies to host...
As we prepare for the year ahead, we also want to take a moment to reflect on all the great things our colleagues accomplished in 2014. We recognize the effort and hard work that went into creating a...
The anticipation, excitement, and happiness of receiving a gift can create a lasting, positive impression on a child, and the Marine Toys for Tots Foundation hopes to offer that experience to...
FDANews Drug Industry Daily Nov. 21, 2014 Europe’s drug regulatory agency has revised the conflict of interest policy for its scientific committee members and experts, a move that one attorney says...
ProPharma Group is proud to call the Kansas City metropolitan area home, and is dedicated to the fight against hunger in our community. This month, we've teamed with Harvesters to provide holiday...
CEO Matthew Weinberg writes for Tobacco Reporter Magazine encouraging stakeholders to take advantage of the opportunity to respond to FDA e-cigarette regulations.
At the end of each year, ProPharma Group holds a special meeting to not only review our annual performance, but also to recognize those colleagues that have gone the extra mile for ProPhama Group...
This month, ProPharma Group enters its 13th year in the pharmaceutical, biotechnology, and medical device industries, and we couldn’t be more thrilled to see what the year has in store for us. Built...
Veteran Life Sciences and Biopharmaceutical Industry Executive Previously Served as ProPharma CEO Raleigh, NC, September 26, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...
RALEIGH, NC, December 6, 2023 – ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and the leading global provider of regulatory, clinical and compliance services...
Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth. Raleigh, NC, October 21, 2024 – ProPharma, the leading global provider of regulatory, clinical, and...
Odyssey Investment Partners ("Odyssey") announced today that it has entered into an agreement to acquire ProPharma Group (or the "Company") from Linden Capital Partners. Financial terms of the...
ProPharma Group and The Planet Group have reached a definitive agreement to merge the two companies. ProPharma Group, a portfolio company of Odyssey Investment Partners, is the leading global...